USA Equities Corp. Reports Fourth Quarter and Full Year 2021 Financial Results
Fourth Quarter 2021 Revenue Up 265% ●Revenue Surpassed $1.4 million for the year ended 2021 Compared to $124,000 for 2020●Gross...
Year: 2022
MIMEDX to Present Health Economics Clinical Data for EPIFIX® in Treatment of Lower Extremity Diabetic Ulcers at SAWC Spring
Company to Sponsor Symposium and Present Three Poster Abstracts MARIETTA, Ga., April 05, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc....
Sunshine Biopharma’s Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer Cells
A Potential Multi-Billion Dollar Global Market Opportunity for Cancer TreatmentsMONTREAL, April 05, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ:...
electroCore Announces Exclusive License Agreement with Teijin for Japan Territory
ROCKAWAY, N.J., April 05, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today...
MBX Biosciences Appoints Ora Hirsch Pescovitz, M.D., to Board of Directors
CARMEL, Ind., April 05, 2022 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing peptide therapeutics with...
NextCure to Present at 21st Annual Needham Virtual Healthcare Conference
BELTSVILLE, Md., April 05, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and...
PepGen Appoints Michelle Mellion, M.D., as Senior Vice President, Head of Clinical Development
Dr. Mellion brings deep experience in neuromuscular disease research and treatment as a biopharma executive, researcher and physicianBOSTON, April 05,...
Chinook Therapeutics, IgA Nephropathy Foundation and Komodo Health Collaborate to Provide Nephrologists with Support and Information to Help Reduce Barriers to Diagnosis and Care
SEATTLE, April 05, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), the IgA Nephropathy Foundation and Komodo Health today...
Kane Biotech Appoints Dr. Gregory Schultz as Chief Scientific Officer
WINNIPEG, Manitoba, April 05, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), announced...
Intra-Cellular Therapies to Present at the 21st Annual Needham Virtual Healthcare Conference
NEW YORK, April 05, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development...
Journal of Clinical Sleep Medicine Publication Shows Efficacy of ProSomnus® Precision Oral Appliance Therapy Devices in Treating Obstructive Sleep Apnea
Study finds that ProSomnus Precision Oral Appliance Therapy Devices Provide Efficacy Comparable to CPAP for Mild and Moderate OSA Precision...
Longeveron Expands Executive Leadership Team; Appoints K. Chris Min, M.D., Ph.D. as Chief Medical Officer
Dr. Min will lead global clinical development and regulatory strategyMIAMI, April 05, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN)...
iCAD Announces Additional Patients Treated Under GLIOX Trial and Continued Global Momentum for Xoft Intraoperative Radiation Therapy (IORT) for Brain, Rectal, Head and Neck Tumor Treatment
Multiple leading institutions leverage the versatility of Xoft electronic brachytherapy (eBx) to increasingly treat multiple cancersNASHUA, N.H., April 05, 2022...
Sema4 and Mount Sinai Use Integrative Network Analysis to Identify Potential New Lung Cancer Therapy
STAMFORD, Conn., April 05, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an artificial intelligence (AI)-driven genomic and clinical data intelligence...
Radius Provides Agenda for Today’s R&D Webcast
Focus: RAD011, an investigational synthetic cannabidiol oral solutionWebcast details: 10:00am to 12:00pm for current or prospective investors and sell side...
OpGen Announces Interim Analysis Results from Clinical Trial for Unyvero Urinary Tract Infection Panel
Interim analysis performed with initial 150 U.S. patient samples enrolled in its prospective multicenter trial for the Unyvero UTI panel...
Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference
CAMBRIDGE, Mass., April 05, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for...
Jushi Holdings Inc. Announces Participation in Upcoming Conferences and Events in April 2022
BOCA RATON, Fla., April 05, 2022 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF),...
Dentsply Sirona to Host First Quarter Conference Call on May 5th
CHARLOTTE, N.C., April 05, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that the Company will be hosting an...
Verrica Pharmaceuticals Announces First Patient Dosed in Phase 2 Study of LTX-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma
LTX-315’s novel mechanism of action directly targets cancerous skin cells to induce an anti-tumor immune response, providing a potential alternative...
